Quality of life issues among women undergoing high-dose chemotherapy for breast cancer

Breast Disease

Volumn 14, Issue , 2001, Pages 41-50

  Partridge, A H ^a   Bunnell, C A ^a   Winer, E P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CHEMOTHERAPY; CLINICAL RESEARCH; COGNITION; CONTROLLED STUDY; DRUG MEGADOSE; EMOTION; FEMALE; HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; ROLE PLAYING; SEXUAL FUNCTION; SOCIAL PSYCHOLOGY; STEM CELL TRANSPLANTATION; SYMPTOM;

EID: 0035674052     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2001-14106     Document Type: Article

References (44)

1. High-dose induction chemotherapy of metastatic breast cancer in protected environment: A prospective randomized study
2. Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy
3. Randomised trial of high-dose chemotherapy and haemopoietic progenitor- cell support in operable breast cancer with extensive axillary lymph- node involvement
4. A prospective, randomized comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes: Preliminary results of 9114/NCIC MA-13
5. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
6. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
7. Randomized phase III study of high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin in operable breast cancer with 4 or more axillary lymph nodes
8. Adjuvant high-dose chemotherapy in breast cancer: Current status
9. Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature
10. Quality of life following bone marrow transplantation
11. Use of quality-of-life outcome assessments in current cancer clinical trials
12. Quality of life following bone marrow transplantation for breast cancer: A comparative study
13. FDA: Quality of life matters!
14. Quality-of-life research in patients with breast cancer
15. Quality of life issues in the treatment of metastatic breast cancer
16. Quality of life end points in cancer clinical trials: Review and recommendations
17. Measuring quality of life today: Methodological aspects
18. Quality of life after bone marrow transplantation
19. Quality of life after bone marrow transplantation
20. Quality of life in breast cancer patients before and after autologous bone marrow transplantation
21. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support
22. Quality of life and psychological distress of bone marrow transplant recipients: The 'time trajectory' to recovery over the first year
23. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study
24. Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantation
25. High-dose sequential chemotherapy with recombinant granulocyte colony- stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility of treatment?
26. Quality of life in the Anglo-Celtic randomized trial of high dose adjuvant chemotherapy
27. Quality of life in a randomized adjuvant breast carcinoma study with standard versus high dose chemotherapy
28. Quality of life in patients with breast cancer randomized to high dose chemotherapy with bone marrow support vs. intermediate dose chemotherapy: CALGB 9066 (companion protocol to CALGB 9082)
29. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B
30. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
31. Patients' psychosocial concerns following stem cell transplantation
32. Psychological distress (PD) induced by dose-dense chemotherapy (CT) in early breast cancer (BC) patients: Results of a phase III multicenter trial (MIG-1)
33. Cognitive dysfunction following adjuvant treatment of breast cancer: A new dose-limiting toxic effect?
34. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
35. Cognitive function in breast cancer patients receiving adjuvant chemotherapy
36. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy
37. Psychosocial predictors of survival: Metastatic breast cancer
38. Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B
39. Psychosocial correlates of survival in advanced malignant disease?
40. Influence of psychological response on survival in breast cancer: A population-based cohort study
41. The psychosocial experience of women treated for breast cancer by high- dose chemotherapy supported by autologous stem cell transplant: A qualitative analysis of support groups
42. Delayed complications and long-term effects after bone marrow transplantation
43. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant
44. Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation